Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Medscape Education: Pioneering Pathways at ESMO 2025

October 6, 2025 |  

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

- PMLiVE

The team will be hosting 5 dynamic satellite symposia at the congress on topics including advances in metastatic breast cancer, personalizing care for prostate cancer, HER2-targeted therapy for gynecologic cancers, and other important topics in oncology. These symposia are designed to engage clinician learners and help them translate the latest data into action through downloadable slides and lively conversation between world-renowned experts. More information on the symposia and links to register are available here.

We invite Congress attendees to stop by the Medscape booth (#1009) in the exhibit hall to connect with the Medscape Oncology team and explore our latest innovations in oncology education, including the launch of the PIONEER Learning Center – PrecIsion Oncology: Navigating EvidEnce for Real-world impact.

“We have very exciting new education in topics like precision oncology that are going to help learners advance their care and reach more patients. We’re looking forward to great meetings and conversations with our oncology colleagues while we’re in Berlin so we can share more about it,” said Zhizhi Fiske

The Medscape team will be attending the congress from 17-20 October.

For more information on Medscape Oncology education, please contact Zhizhi Fiske

 

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professionals.

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

Making an Impact at ASH 2023

Medscape has left behind the sunny skies of San Deigo, having attended their final conference of the year at the ASH annual meeting.The team wrapped up the year with a...

Women’s Health Faces Some Difficult Headwinds. Here’s How We Can Move Forward

When it comes to women’s health, “we are a bit behind — almost where oncology was 20 years ago and neuroscience was about 10 years ago,” says Sandra Milligan, Head...

Hear from her: A Passionate Cause: Elevating Women to Reshape Medicine

Hear from her: A “Leaky Pipeline” and the Loss of Talented Female Physicians

Hear from Her: Planting the Seeds for Future Women Leaders in Medicine

A “Leaky Pipeline” and the Loss of Talented Female Physicians

A leaky pipeline that begins during medical school and extends throughout the training process means we lose many talented women, says Fatima Rodriguez, director of preventive cardiology and associate professor...

Medscape Oncology’s Large Presence at ASH 2023

Medscape Education is returning to the annual ASH conference with eight symposia, two publications, and the opportunity for clinicians to challenge their knowledge with MedChallenge.The eight symposia will be held...

Medscape Education Redefines Standards with Website Redesign

Medscape Education—the number 1 destination for CME—--has launched a redesign of its education hub. The site now features easy-to-navigate categories, a highlight on curricula, and enhanced search capabilities, allowing Medscape...

The Power of the Partnership: How Patient-Centricity Improves Care

How can the patient’s voice improve care?This was the question Medscape Oncology Clinical Strategist Victoria Harvey-Jones, PhD and Lesley Fallowfield DBE, BSC, DPHIL, FMEDSCI, Professor of Pyscho-Oncology, Sussex Health Outcomes...

World AIDS Day 35: Medscape’s Commitment to the Elimination of HIV through Education and Looking Towards the Future

December 1 marks the 35th year commemorating World AIDS Day, and the theme is “Remember and Commit.” While new infections have steadily declined over the last several years, HIV remains a...